about
Burden of atopic dermatitis in Japanese adults: Analysis of data from the 2013 National Health and Wellness Survey.The patient-reported disease burden in adults with atopic dermatitis: a cross-sectional study in Europe and CanadaDupilumab in adolescents with uncontrolled moderate-to-severe atopic dermatitis: results from a phase IIa open-label trial and subsequent phase III open-label extensionDupilumab provides important clinical benefits to patients with atopic dermatitis who do not achieve clear or almost clear skin according to the Investigator's Global Assessment: a pooled analysis of data from two phase III trials
P50
description
researcher (ORCID 0000-0002-7801-4125)
@en
wetenschapper
@nl
name
L Eckert
@en
L Eckert
@nl
type
label
L Eckert
@en
L Eckert
@nl
prefLabel
L Eckert
@en
L Eckert
@nl
P31
P496
0000-0002-7801-4125